ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research cover art

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

By: American College of Cardiology
Listen for free

About this listen

 The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.American College of Cardiology Foundation. All rights reserved. Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Top Takeaways from 2025: Preventive Cardiology with C. Noel Bairey Merz, MD, MACC

    Top Takeaways from 2025: Preventive Cardiology with C. Noel Bairey Merz, MD, MACC
    Dec 18 2025
    In this interview, C. Noel Bairey Merz MD, MACC and Alison L. Bailey, MD FACC, discuss the Top Preventive Cardiology Takeaways from 2025 including trials clopidogrel versus aspirin, the benefit of vaccines, statin use in pregnancy, and more. Suggested Materials: Valgimigli M, Choi KH, Giacoppo D, et al. Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. Lancet. 2025;406(10508):1091-1102. doi:10.1016/S0140-6736(25)01562-4 O'Leary K. Influenza vaccination benefits patients with heart failure. Nature Medicine. 2025. doi: https://doi.org/10.1038/d41591-025-00058-0 Christensen JJ, Holven KB, Bogsrud MP, et al. Statin use in pregnancy and risk of congenital malformations: a Norwegian nationwide study. Eur Heart J. Published online August 21, 2025. doi:10.1093/eurheartj/ehaf592 Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475-1503. doi:10.1002/oby.24336 Brett AS. New Variations on GLP-1–Receptor Agonists are Coming (NEJM/Clinician website). 2025. Available at: https://clinician.nejm.org/new-variations-glp-1receptor-agonists-coming-nejm-jw.NA58926. Accessed 12/17/25. Subscribe on Apple Podcasts | Subscribe to ACCEL
    Show More Show Less
    15 mins
  • Top Takeaways from 2025: EP with DJ Lakkireddy, MBBS, FACC

    Top Takeaways from 2025: EP with DJ Lakkireddy, MBBS, FACC
    Dec 17 2025
    In this interview, DJ Lakkireddy, MBBS, FACC and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology Takeaways from 2025 including trials CLOSURE-AF, ALONE-AF, NEMESIS-PFA, and more. Suggested Materials: 1. Verma A, Birnie DH, Jiang C, et al. Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. N Engl J Med. Published online November 8, 2025. doi:10.1056/NEJMoa2509688 2. Landmesser U, Skurk C, Kirchhof P, et al. Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial. Am Heart J. Published online September 12, 2025. doi:10.1016/j.ahj.2025.09.005 3. Kim D, Shim J, Choi EK, et al. Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial. JAMA. 2025;334(14):1246-1254. doi:10.1001/jama.2025.14679 4. Lakkireddy D, Katapadi A, Garg J, et al. NEMESIS-PFA: Investigating Collateral Tissue Injury Associated With Pulsed Field Ablation. JACC Clin Electrophysiol. 2025;11(8):1747-1756. doi:10.1016/j.jacep.2025.04.017 5. Wazni OM, Saliba WI, Nair DG, et al. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med. 2025;392(13):1277-1287. doi:10.1056/NEJMoa2408308 Subscribe on Apple Podcasts | Subscribe to ACCEL
    Show More Show Less
    19 mins
  • Multimodality Imaging in Inflammatory Cardiomyopathy

    Multimodality Imaging in Inflammatory Cardiomyopathy
    Dec 16 2025

    Multimodality imaging plays a pivotal role in evaluating inflammatory cardiomyopathy, particularly when cardiac sarcoidosis (CS) is suspected. Symptoms of CS include unexplained high-grade AV block, ventricular arrhythmias, reduced left ventricular function, or regional wall thinning without coronary disease. The best evaluation combines cardiac magnetic resonance imaging (MRI) for structural and scar assessment with fluorodeoxyglucose (FDG)-positron emission tomography (PET) for detecting active inflammation and extracardiac involvement.

    In this interview, Michelle Kittleson MD, FACC and Ron Blankstein, MD, FACC discuss "Multimodality Imaging in Inflammatory Cardiomyopathy."

    Subscribe on Apple Podcasts | Subscribe to ACCEL

    Show More Show Less
    9 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.